Patent · US Active

Antifungal composition

US8952070B2 · kind B2 · utility

7Cited by

5References

10Claims

0Family size

Assignee

Moberg Pharma AB · SE

Inventor

Ake Lindahl · Malmö, SE

Key dates

Filing date	Feb 10, 2012
Grant date	Feb 10, 2015
Priority date	—
Expiry date	Feb 10, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided a pharmaceutical composition for the treatment of fungal infection of the nail comprising a anti-fungal allylamine compound present in an amount of about 10%, an organic acid or an ester thereof, a diol and a sequestering agent where the pharmacological composition is essentially water-free.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.